These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 3129738)

  • 41. Chemotherapy for metastatic bladder cancer; the EORTC experience.
    Stoter G
    Prog Clin Biol Res; 1988; 260():471-9. PubMed ID: 3283767
    [No Abstract]   [Full Text] [Related]  

  • 42. Management of disseminated disease in the patient with bladder cancer.
    Perry JJ; Muss HB
    Urol Clin North Am; 1994 Nov; 21(4):661-72. PubMed ID: 7974898
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Adjuvant chemotherapy following total cystectomy for invasive bladder cancer with bleomycin, vincristine and methotrexate].
    Takeuchi S; Yamada T; Sekine H; Katoh M; Washizuka M; Fukui I; Yokokawa M
    Hinyokika Kiyo; 1984 Nov; 30(11):1619-25. PubMed ID: 6084949
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Survival and neo-adjuvant chemotherapy in invasive bladder cancer.
    Hall RR
    Prog Clin Biol Res; 1988; 269():569-77. PubMed ID: 3293072
    [No Abstract]   [Full Text] [Related]  

  • 45. [Chemotherapy for advanced bladder cancer: clinical evaluation of chemotherapy for locally advanced or metastatic bladder cancer and adjuvant chemotherapy for deeply invasive bladder cancer following radical cystectomy].
    Uekado Y; Ogawa T; Yoshida T; Yamamoto S; Hirano A; Watanabe T; Shinka T; Ohkawa T
    Hinyokika Kiyo; 1985 Aug; 31(8):1365-70. PubMed ID: 3841260
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Prognosis in pT3b infiltrating tumors of the bladder treated by adjuvant chemotherapy].
    Sahwi A; Robert M; Delbos O; Legouffe E; Guiter J; Navratil H
    Prog Urol; 1998 Dec; 8(6):1007-11. PubMed ID: 9894259
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adjuvant chemotherapy in advanced bladder cancer. Italian Uro-Oncologic Cooperative Group.
    Bono AV; Benvenuti C; Reali L; Pozzi E; Gibba A; Cosciani-Cunico S; Comuzzi U; Anselmo G
    Prog Clin Biol Res; 1989; 303():533-40. PubMed ID: 2675010
    [No Abstract]   [Full Text] [Related]  

  • 48. Current status of bladder cancer protocols in the EORTC Genito-Urinary Group.
    Denis L; Pavone-Macaluso M; De Pauw M
    Prog Clin Biol Res; 1984; 162B():429-39. PubMed ID: 6390450
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ongoing trials in bladder cancer conducted by the EORTC Genito-Urinary Tract Cancer Cooperative Group.
    De Pauw M
    Prog Clin Biol Res; 1988; 260():215-23. PubMed ID: 3283760
    [No Abstract]   [Full Text] [Related]  

  • 50. [Concurrent radio-chemotherapy in infiltrating cancer of the bladder: a new therapeutic approach?].
    Housset M; Dufour B; Durdux C; Chrétien Y; Méjean A; Baillet F
    Cancer Radiother; 1998 Apr; 2 Suppl 1():67s-72s. PubMed ID: 9749082
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Role of systemic chemotherapy in the treatment of infiltrating cancer of the bladder].
    Gardella S; Estapé J
    Med Clin (Barc); 1989 Dec; 93(18):693-5. PubMed ID: 2607820
    [No Abstract]   [Full Text] [Related]  

  • 52. Improving the prognosis of patients after radical cystectomy. Part II: the role of perioperative chemotherapy.
    Suttmann H; Kamradt J; Lehmann J; Stöckle M
    BJU Int; 2007 Dec; 100(6):1225-8. PubMed ID: 17979921
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neoadjuvant chemotherapy in T3-4 N0-X M0 transitional cell carcinoma of the bladder. Problems of clinical and pathological evaluation of response.
    Splinter TA; ten Kate FJ; Schröder FH; Denis L; Newling D; Jones WG; Jacqmin D; Boeken Kruger CG; Stoter G; de Voogt HJ
    Prog Clin Biol Res; 1988; 269():579-90. PubMed ID: 3393555
    [No Abstract]   [Full Text] [Related]  

  • 54. Impact of methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy in patients with lymph node metastases from transitional cell carcinoma of the lower urinary tract.
    Koch MO; Coussens D
    Semin Urol; 1993 Feb; 11(1):14-9. PubMed ID: 8465122
    [No Abstract]   [Full Text] [Related]  

  • 55. Radical hypofractionated accelerated radiotherapy with cytoprotection for invasive bladder cancer.
    Koukourakis MI; Tsolos C; Touloupidis S
    Urology; 2007 Feb; 69(2):245-50. PubMed ID: 17320657
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The optimal management of T1G3 bladder cancer.
    Emiliozzi P; Pansadoro A; Pansadoro V
    BJU Int; 2008 Nov; 102(9 Pt B):1265-73. PubMed ID: 19035891
    [No Abstract]   [Full Text] [Related]  

  • 57. Preoperative chemotherapy in T3-T4 Nx Mo bladder cancer with cisplatinum and methotrexate.
    Denis L; Da Silva FC; Hendrickx L
    Prog Clin Biol Res; 1988; 260():571-7. PubMed ID: 3362906
    [No Abstract]   [Full Text] [Related]  

  • 58. A phase I/II trial of transurethral surgery combined with concurrent cisplatin, 5-fluorouracil and twice daily radiation followed by selective bladder preservation in operable patients with muscle invading bladder cancer.
    Zietman AL; Shipley WU; Kaufman DS; Zehr EM; Heney NM; Althausen AF; McGovern FJ
    J Urol; 1998 Nov; 160(5):1673-7. PubMed ID: 9783929
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Induction chemotherapy in association with preoperative radiotherapy and cystectomy in bladder carcinoma--a preliminary report.
    Andersson L; Esposti PL; Fosså SD; Sander S
    Prog Clin Biol Res; 1988; 260():621-3. PubMed ID: 3362910
    [No Abstract]   [Full Text] [Related]  

  • 60. Pre surgery chemotherapy in bladder cancer.
    Francini M; Veronesi A; Dal Bo V; Carbone A; Monfardini S
    Prog Clin Biol Res; 1988; 260():585-9. PubMed ID: 3362908
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.